Vetera 2XPThis page contains information on Vetera 2XP for veterinary use.
The information provided typically includes the following:
- Vetera 2XP Indications
- Warnings and cautions for Vetera 2XP
- Direction and dosage information for Vetera 2XP
Vetera 2XPThis treatment applies to the following species:
Equine Rhinopneumonitis-Influenza Vaccine
Vetera 2XP Indications
For vaccination of healthy horses 4 months of age or older as an aid in reduction of respiratory diseases caused by Equine Herpesvirus types 1 and 4 (EHV-1 and EHV-4); and as an aid in the reduction of respiratory disease and shedding caused by A2 Equine Influenza virus. Product contains Kentucky Lineage (KY/95), Florida sublineage clade 1 (OH/03), and Florida sublineage clade 2 (RI/07) equine influenza strains. Efficacy (DOI) has been demonstrated for at least 6 months against OH/03.
Administration and dosage: Shake well before use. Using aseptic technique, inoculate horses intramuscularly with a 1 mL dose. Administer a second 1 mL dose intramuscularly in 3-4 weeks using a different injection site. Revaccinate annually and prior to anticipated exposure with a single 1 mL intramuscular dose.
PrecautionsStore at 35-45°F (2-7°C). Protect from freezing. Do not vaccinate within 21 days
before slaughter. Use entire contents when first opened. Anaphylactoid reactions may occur following use. Antidote: Epinephrine.
This product has been tested under laboratory conditions and shown to meet all Federal standards for safety and efficacy in normal, healthy, immunocompetent animals. This level of performance may be affected by conditions such as stress, weather, nutrition, disease, parasitism, other treatments, individual idiosyncrasies, or impaired immunological competency. These factors should be considered by the user when evaluating product performance or freedom from reactions.
Preservatives: Gentamicin and Amphotericin B.
For Veterinary Use Only
Vetera® is a registered trademark of Boehringer Ingelheim Vetmedica GMBH.
© 2013 Boehringer Ingelheim Vetmedica, Inc. All Rights Reserved.
Boehringer Ingelheim Vetmedica, Inc., St. Joseph, MO 64506
US Vet. Lic. No. 124
US Patent No. 7572620. Used under license.
1 Dose/1 mL
10 Doses/10 mL
NAC No.: 1028288.0
2621 NORTH BELT HIGHWAY, ST. JOSEPH, MO, 64506-2002
|Every effort has been made to ensure the accuracy of the Vetera 2XP information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.|
Copyright © 2017 North American Compendiums. Updated: 2017-11-28